2026. The Role of Immunometabolic Dysregulation in Obesity-Associated Cardiovascular Risk: A Narrative Review. Journal of Evidence-Based Medical Research. 2, 1 (Mar. 2026). DOI:https://doi.org/10.66687/jebmr.2.1.2026.29.